Insider Transactions Reported by 16 Insiders of HARROW, INC.

Symbol
HROW on Nasdaq
Location
Nashville, TN

Quick Takeaways

  • HROW - HARROW, INC. has 16 insiders with reported activity on this page.
  • Net insider value flow over the last year: -$10,643,994.
  • Recent transaction rows are available for direct filing-level review.

What Changed

  • Buy value: ; sell value: $10,643,994.
  • Net share flow: -273,572.

Why This Matters

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to selling over the last 12 months. Net value: -$10,643,994.

Buys

$0

Shares: 0

Insiders: 0

Sells

$10,643,994

Shares: 273,572

Insiders: 1

Net

-$10,643,994

Shares: -273,572

Insiders: -1

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 203,572 $0 $8,117,326 -$8,117,326
3-6 0 20,000 $0 $1,066,914 -$1,066,914
6-9 0 0 $0 $0 $0
9-12 0 50,000 $0 $1,459,755 -$1,459,755

HARROW, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Opaleye Management Inc. 10%+ Owner $146,049,979 -$10,643,994 -6.8% Filing P/S 03 Mar 2026
Mark L. Baum CHIEF EXECUTIVE OFFICER, Director $140,527,277 Mixed 12 Dec 2025
Andrew R. Boll President And Cfo $38,174,083 Mixed 12 Dec 2025
John P. Saharek CEO & President, ImprimisRx $10,791,989 Mixed 03 Apr 2025
Richard L. Lindstrom MD Director $1,022,671 Mixed 30 Sep 2022
Martin A. Makary Director $364,950 Mixed 14 Jun 2024
Teresa Sparks Director Mixed 21 Jun 2023
Robert J. Kammer Director Mixed 25 Jun 2021
R. Lawrence van Horn Director Mixed 21 Jun 2023
Francis William Mullery Jr. CEO, ImprimisRx Mixed 06 Oct 2025
Patrick William Sullivan Chief Commercial Officer Mixed 30 Jan 2026
Amir Shojaei Chief Scientific Officer Mixed 06 Jan 2025
Lauren P. Silvernail Director Mixed 20 Jun 2025
Perry J. Sternberg Director Mixed 20 Jun 2025
Randall E. Pollard Chief Accounting Officer Mixed 01 Sep 2025
Adrienne L. Graves Director Mixed 20 Jun 2025

Top shareholders of HARROW, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Opaleye Management Inc.
13F 3/4/5
Company · 10%+ Owner
9.9%
from 3/4/5
3,905,000
$191,345,000 31 Dec 2025
Mark L. Baum
3/4/5 13D/G
CHIEF EXECUTIVE OFFICER, Director
11%
from 13D/G
3,875,630
mixed-class rows
$140,527,277 12 Dec 2025
BlackRock, Inc.
13F
Company
6.9%
2,568,402
$125,851,698 31 Dec 2025
13F
VANGUARD GROUP INC
13F
Company
5.2%
1,921,683
$94,162,467 31 Dec 2025
13F
Private Capital Management, LLC
13F
Company
4.9%
1,843,091
$90,311,459 31 Dec 2025
13F
Daniel L. Kaufman
13D/G
Daniel Kaufman
5%
1,878,000
$88,491,360 $0 10 Mar 2026
Luxor Capital Group, LP
13F
Company
2.5%
917,541
$44,959,509 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.1%
785,089
$38,476,665 31 Dec 2025
13F
STATE STREET CORP
13F
Company
2.1%
783,740
$38,403,260 31 Dec 2025
13F
Andrew R. Boll
3/4/5
PRESIDENT AND CFO
mixed-class rows
1,216,929
mixed-class rows
$38,174,083 12 Dec 2025
ROYCE & ASSOCIATES LP
13F
Company
1.4%
509,746
$24,977,554 31 Dec 2025
13F
Penn Capital Management Company, LLC
13F
Company
1.1%
392,067
$19,257,312 31 Dec 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.99%
370,548
$18,158,870 31 Dec 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.98%
366,533
$17,960,117 31 Dec 2025
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.97%
361,998
$17,737,902 31 Dec 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.84%
312,071
$15,291,479 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
0.81%
300,865
$14,742,385 31 Dec 2025
13F
BRAIDWELL LP
13F
Company
0.79%
295,291
$14,469,259 31 Dec 2025
13F
Diametric Capital, LP
13F
Company
0.75%
278,101
$13,626,949 31 Dec 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.73%
272,612
$13,357,988 31 Dec 2025
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.68%
252,019
$12,348,931 31 Dec 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.67%
249,421
$12,221,629 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.64%
239,265
$11,723,985 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
0.63%
233,755
$11,454,038 31 Dec 2025
13F
UBS Group AG
13F
Company
0.6%
222,362
$10,895,738 31 Dec 2025
13F
John P. Saharek
3/4/5
CEO & President, ImprimisRx
class O/S missing
467,388
$10,791,989 03 Apr 2025
STIFEL FINANCIAL CORP
13F
Company
0.57%
212,493
$10,412,157 31 Dec 2025
13F
MARSHALL WACE, LLP
13F
Company
0.54%
200,307
$9,815,043 31 Dec 2025
13F
Ikarian Capital, LLC
13F
Company
0.49%
183,347
$8,984,003 31 Dec 2025
13F
Westside Investment Management, Inc.
13F
Company
0.49%
181,351
$8,886,224 31 Dec 2025
13F
FIRST TRUST ADVISORS LP
13F
Company
0.41%
152,231
$7,459,319 31 Dec 2025
13F
Invesco Ltd.
13F
Company
0.39%
145,406
$7,124,894 31 Dec 2025
13F
Blackhawk Capital Partners, LLC
13F
Company
0.36%
134,758
$6,603,142 31 Dec 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.29%
109,638
$5,372,262 31 Dec 2025
13F
GROUP ONE TRADING LLC
13F
Company
0.29%
108,622
$5,322,478 31 Dec 2025
13F
WOODMONT INVESTMENT COUNSEL LLC
13F
Company
0.28%
105,339
$5,161,611 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.28%
104,979
$5,143,971 31 Dec 2025
13F
Russell Investments Group, Ltd.
13F
Company
0.28%
103,928
$5,092,493 31 Dec 2025
13F
Crawford Fund Management, LLC
13F
Company
0.28%
103,400
$5,066,600 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.26%
95,359
$4,672,591 31 Dec 2025
13F
FirstWave Capital Management LLC
13F
Company
0.25%
93,953
$4,603,697 31 Dec 2025
13F
12th Street Asset Management Company, LLC
13F
Company
0.24%
91,123
$4,465,027 31 Dec 2025
13F
Lumbard & Kellner, LLC
13F
Company
0.24%
88,312
$4,327,288 31 Dec 2025
13F
Steward Partners Investment Advisory, LLC
13F
Company
0.22%
83,689
$4,100,761 31 Dec 2025
13F
Bank of New York Mellon Corp
13F
Company
0.22%
80,990
$3,968,510 31 Dec 2025
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
0.19%
69,959
$3,427,991 31 Dec 2025
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.18%
67,229
$3,294,221 31 Dec 2025
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.17%
64,274
$3,149,426 31 Dec 2025
13F
Nuveen, LLC
13F
Company
0.17%
63,038
$3,088,862 31 Dec 2025
13F
Swiss National Bank
13F
Company
0.17%
62,100
$3,042,900 31 Dec 2025
13F

Recent Insider Transactions by Companies or Individuals for HARROW, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -6.69% $169,122 $39.67 -4,263 59,428 04 Mar 2026 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -3.57% $5,316,061 $39.67 -134,000 3,622,000 04 Mar 2026 By Opaleye, L.P.
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -2.01% $51,250 $39.15 -1,309 63,691 03 Mar 2026 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -1.55% $2,309,992 $39.15 -59,000 3,756,000 03 Mar 2026 By Opaleye, L.P.
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -7.14% $270,900 $54.18 -5,000 65,000 27 Feb 2026 By Managed Account
Patrick William Sullivan HROW RSU Award 40,000 25,000 30 Jan 2026 Direct
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -22.2% $1,066,914 $53.35 -20,000 70,000 06 Jan 2026 By Managed Account
Andrew R. Boll HROW Common Stock Tax liability -3.18% -26,665 811,179 12 Dec 2025 Direct
Andrew R. Boll HROW Common Stock Options Exercise 7.71% 60,000 837,844 12 Dec 2025 Direct
Andrew R. Boll HROW Stock Option (Right to Buy) Options Exercise -100% -60,000 0 12 Dec 2025 Direct
Mark L. Baum HROW Common Stock Tax liability -2.61% -79,994 2,986,130 12 Dec 2025 Direct
Mark L. Baum HROW Common Stock Options Exercise 6.24% 180,000 3,066,124 12 Dec 2025 Direct
Mark L. Baum HROW Stock Option (Right to Buy) Options Exercise -100% -180,000 0 12 Dec 2025 Direct
Randall E. Pollard HROW Stock Option (Right to Buy) Award 30,000 30,000 01 Sep 2025 Direct
Mark L. Baum HROW Common stock Tax liability -9.79% -313,338 2,886,124 21 Jul 2025 Direct
Mark L. Baum HROW Common stock Options Exercise 23.1% 600,000 3,199,462 21 Jul 2025 Direct
Andrew R. Boll HROW RSU Award 405,750 405,750 01 Jul 2025 Direct
Mark L. Baum HROW RSU Award 889,500 889,500 01 Jul 2025 Direct
Perry J. Sternberg HROW RSU Award 7,339 7,339 20 Jun 2025 Direct
Lauren P. Silvernail HROW RSU Award 7,339 7,339 20 Jun 2025 Direct
Adrienne L. Graves HROW RSU Award 7,339 7,339 20 Jun 2025 Direct
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -14.3% $462,033 $30.80 -15,000 90,000 10 Jun 2025 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -12.6% $461,794 $30.37 -15,204 105,000 09 Jun 2025 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -1.47% $53,907 $30.02 -1,796 120,204 04 Jun 2025 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -2.4% $90,116 $30.04 -3,000 122,000 03 Jun 2025 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -3.85% $132,945 $26.59 -5,000 125,000 13 May 2025 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -7.14% $258,959 $25.90 -10,000 130,000 12 May 2025 By Managed Account
* An asterisk sign (*) next to the price indicates that the price is likely invalid.